GALECTIN THERAPEUTICS INC — Director's Dealing 2013

Jul 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-07-01

Reporting Person: MAULDIN JOHN F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-01	Common Stock	P	300	$4.2433	Acquired	13476	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4947	Indirect

Footnotes

F1: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.

F2: Reflects weighted average price. Range of prices were between $4.23 and $4.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.